NVNO

enVVeno Medical Corp

Company with tickers: NVNO

CIK
1661053
CUSIP
29415J205
Shares Outstanding
667,669
Line Item Value
Revenue
Revenue (ASC 606)
Cost of Revenue
Gross Profit
Operating Expenses
Research & Development $2,111,000
Operating Income $-4,062,000
Net Income $-3,849,000
EPS (Basic) $-5.89
EPS (Diluted) $-5.89